Apolipoprotein L 2 anticorps (C-Term)

N° du produit ABIN6746314

Détail du produit anti-Apolipoprotein L 2 anticorps

Antigène: Apolipoprotein L 2 (APOL2) (Apolipoprotein L, 2 (APOL2))

Épitope: C-Term

Reactivité: Humain

Hôte: Lapin

Clonalité: Polyclonal

Conjugué: Cet anticorp Apolipoprotein L 2 est non-conjugé

Application: Western Blotting (WB)

Specificité: Human APOL2 / Apolipoprotein L 2

Homologie: Percent identity by BLAST analysis: Human (100%).

Purification: Immunoaffinity purified

Immunogène: Synthetic peptide from C-Terminus of human APOL2 (Q9BQE5, NP_112092). Percent identity by BLAST analysis: Human (100%), Gorilla, Monkey (92%).

Type of Immunogen: Synthetic peptide

Information d'application

Indications d'application: Approved: WB (0.2 - 1 μg/mL)

Usage: Western Blot: Suggested dilution at 1 μg/mL in 5 % skim milk / PBS buffer, and HRP conjugated anti-Rabbit IgG should be diluted in 1: 50,000 - 100,000 as secondary antibody.

Commentaires:

Target Species of Antibody: Human

Restrictions: For Research Use only

Stockage

Format: Lyophilized

Reconstitution: Distilled water

Concentration: Lot specific

Buffer: Lyophilized from PBS with 2 % sucrose

Conseil sur la manipulation: Avoid repeat freeze-thaw cycles.

Stock: 4 °C,-20 °C

Stockage commentaire: Long term: -20°C, the use of 50% glycerol is recommended if storing aliquots in -20°C for long term use (up to 1 year)
Short term (less than 1 week): 4°C. Avoid freeze-thaw cycles.

Détails sur Apolipoprotein L 2

Antigène: Apolipoprotein L 2 (APOL2) (Apolipoprotein L, 2 (APOL2))

Autre désignation: APOL2 / Apolipoprotein L 2 (APOL2 Produits)

Synonymes: anticorps APOL3, anticorps APOL-II, anticorps Apol8, anticorps APOL2, anticorps apolipoprotein L2, anticorps apolipoprotein L, 2, anticorps APOL2, anticorps Apol2, anticorps LOC619179

Sujet: Name/Gene ID: APOL2

Synonyms: APOL2, APOL-II, Apolipoprotein L2, Apolipoprotein L, 2, Apolipoprotein L-II

ID gène: 23780

NCBI Accession: NP_112092

UniProt: Q9BQE5

Pathways: Phosphorylation & l'infection par le SRAS-CoV-2